Direct Oral Anticoagulants in Antithrombin Deficiency: Initial Experience in a Single Center.

Competing Interests: B.S.B. has nothing to disclose. R.M. has nothing to disclose. M.V.L. has nothing to disclose. K.M. reports grants, speaker fees, and travel support from Bayer, grants and speaker fees from Sanquin, grants from Pfizer, speaker fees from Boehringer Ingelheim, speaker fees from BMS, speaker fees from Aspen, consulting fees from Uniqure, outside the submitted work.